Patterns, predictors, variations, and temporal trends in emergency medical service hospital prenotification for acute ischemic stroke. by Lin, Cheryl B et al.
UCLA
UCLA Previously Published Works
Title
Patterns, predictors, variations, and temporal trends in emergency medical service hospital 
prenotification for acute ischemic stroke.
Permalink
https://escholarship.org/uc/item/1412h5n4
Journal
Journal of the American Heart Association, 1(4)
ISSN
2047-9980
Authors
Lin, Cheryl B
Peterson, Eric D
Smith, Eric E
et al.
Publication Date
2012-08-24
DOI
10.1161/JAHA.112.002345
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
ORIGINAL RESEARCH
Patterns, Predictors, Variations, and Temporal Trends in Emergency
Medical Service Hospital Prenotification for Acute Ischemic Stroke
Cheryl B. Lin, BS; Eric D. Peterson, MD, MPH; Eric E. Smith, MD, MPH; Jeffrey L. Saver, MD; Li Liang, PhD; Ying Xian, MD, PhD; DaiWai M.
Olson, PhD, RN; Bimal R. Shah, MD, MBA; Adrian F. Hernandez, MD, MHS; Lee H. Schwamm, MD; Gregg C. Fonarow, MD
Background——-Emergency medical services (EMS) hospital prenotification of an incoming stroke patient is guideline recommended
as a means of increasing the timeliness with which stroke patients are evaluated and treated. Still, data are limited with regard to
national use of, variations in, and temporal trends in EMS prenotification and associated predictors of its use.
Methods and Results——-We examined 371 988 patients with acute ischemic stroke who were transported by EMS and enrolled
in 1585 hospitals participating in Get With The Guidelines—Stroke from April 1, 2003, through March 31, 2011. Prenotification
occurred in 249 197 EMS-transported patients (67.0%) and varied widely by hospital (range, 0% to 100%). Substantial variations
by geographic regions and by state, ranging from 19.7% in Washington, DC, to 93.4% in Montana, also were noted. Patient factors
associated with lower use of prenotification included older age, diabetes mellitus, and peripheral vascular disease. Prenotification
was less likely for black patients than for white patients (adjusted odds ratio 0.94, 95% confidence interval 0.92–0.97, P<0.0001).
Hospital factors associatedwith greater EMS prenotification usewere absence of academic affiliation, higher annual volume of tissue
plasminogen activator administration, and geographic location outside the Northeast. Temporal improvements in prenotification
rates showed a modest general increase, from 58.0% in 2003 to 67.3% in 2011 (P temporal trend <0.0001).
Conclusions——-EMShospital prenotification is guideline recommended, yet among patients transported toGetWith TheGuidelines—
Stroke hospitals it is not provided for 1 in 3 EMS-arriving patients with acute ischemic stroke and varies substantially by hospital,
state, and region. These results support the need for enhanced implementation of stroke systems of care. ( J Am Heart Assoc.
2012;1:e002345 doi: 10.1161/JAHA.112.002345.)
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S troke remains a leading cause of mortality and mor-bidity in the United States.1 Stroke outcomes can be
improved significantly with the use of intravenous tissue plas-
minogen activator (tPA) for acute ischemic stroke.2–4 Because
the benefits of tPA correlate inversely with the time to therapy
administration,2–5 the American Heart Association / Amer-
ican Stroke Association (AHA/ASA) have set guidelines for
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rapid tPA use. A recommended strategy to improve timeli-
ness of stroke evaluation and treatment is for patients with
acute stroke to be transported by emergency medical services
(EMS) and for EMS to prenotify the hospital of an incoming
patient.6–12 This prenotification can facilitate earlier mobiliza-
tion of the stroke team, with activation of stroke processes of
care at the receiving hospital even before patient arrival. The
AHA/ASA and the National Association of Emergency Medi-
cal Services Physicians support the practice of EMS prenoti-
fication in stroke care,6,7 recognizing its potential to increase
the timeliness with which eligible patients receive tPA. De-
spite these national recommendations, contemporary data are
scarce with regard to national use of EMS prenotification and
factors associated with its use in a broad cohort of patients
with stroke throughout the United States.
The aim of this study was to use data from the AHA/ASA’s
GetWith TheGuidelines (GWTG)—Stroke registry to (1) describe
the rate of EMS prenotification use; (2) identify variation in EMS
prenotification by hospital, state, and region; (3) determine pa-
tient and hospital factors associated with EMS prenotification
from 2003 to 2011; and (4) evaluate temporal trends in EMS
prenotification from 2003 to 2011.
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Methods
GWTG-Stroke is an initiative undertaken by the AHA/ASA to
improve the quality of care delivered to patientswith stroke and
transient ischemic attack (TIA) through changes implemented
at the hospital level. Details of the design and conduct of
the GWTG-Stroke program have been described previously.5,13
GWTG uses a Web-based patient management tool (Outcome
Sciences, Inc, Cambridge, MA) to collect clinical data on con-
secutively admitted patients, provide decision support, and
enable real-time online reporting features. After a year-long pi-
lot phase, the GWTG-Stroke program was made available to all
hospitals across the United States in April 2003.5,13 Each par-
ticipating hospital received either human research approval
to enroll cases without individual patient consent under the
common rule or a waiver of authorization and exemption from
subsequent review by the hospital’s institutional review board.
Outcome Sciences, Inc, serves as the data collection and coor-
dination center for GWTG. The Duke Clinical Research Institute
serves as the data analysis center and has an agreement to
analyze the aggregate, deidentified data for research purposes.
Hospital site personnel were trained to collect data on
consecutive patients admitted with the principal clinical di-
agnosis of acute stroke or TIA by prospective clinical identi-
fication, retrospective identification through discharge codes,
or a combination of the two. Methods used for the prospective
clinical identification of cases involved regular review of sev-
eral data sources, including emergency department admission
logs, ward census logs, intensive care unit logs, and neurol-
ogy service consultations. Methods used for the retrospective
clinical identification of cases included regular surveillance of
discharge codes, specifically International Classification of Dis-
eases, 9th Revision codes 433.xx, 434.xx, and 436 for ischemic
stroke. The eligibility of all acute stroke admissions was con-
firmed before chart abstraction.5,13
Patient data were abstracted by trained hospital person-
nel and included demographics; medical history; onset time of
stroke symptoms (defined as last time patient was known to be
well); mode of arrival; arrival time; in-hospital diagnostic stud-
ies, treatments, and procedures; time of initial imaging study;
tPA treatment initiation time; tPA complications; in-hospital
death; and discharge treatments, counseling, and destination.
The National Institutes of Health Stroke Scale (NIHSS) was
used to index stroke severity, when documented. Data col-
lectors at hospital facilities indicated mode of patient arrival
under the following classifications: EMS from home/scene,
hospital transfer, private transport / walk in, or not docu-
mented. If applicable, they further recorded if there had been
EMS prenotification to the hospital for the patient in question.
The criterion for identifying prenotification was explicit docu-
mentation anywhere in the records that advance notification
by EMS had occurred and that this notification had indicated,
through the use of the word stroke or any documentation of
signs and symptoms consistent with stroke, that the patient
was a suspected stroke patient. All patient data were deidenti-
fied before submission. Data on hospital-level characteristics
(eg, number of beds, geographic region, teaching status) were
accessed from the American Hospital Association.14
A total of 936 702 patients with acute ischemic stroke
from 1635 hospitals were enrolled between April 1, 2003,
and April 2, 2011. Patients who had in-hospital strokes
(n=15 985) and those transferred in from other acute care
facilities (n=94 061) were excluded for the purpose of this
study. Of the remaining patients, 404 031 did not arrive by
EMS from home/scene. Another 50 637 (12.0%) patients who
were transported by EMS had missing prenotification data and
were therefore excluded, leaving 371 988 EMS-transported
patients, who constituted the study population. The char-
acteristics of patients with and without documentation of
EMS prenotification are shown in online-only Data Supplement
Table I.
Statistical Analysis
Sociodemographic factors, clinical variables, hospital charac-
teristics, and quality-of-care measures were compared be-
tween patients transported by EMS with prenotification ver-
sus those without prenotification. The Pearson χ2 test and
Wilcoxon rank-sum test were used to compare categorical
and continuous variables, respectively. Categorical and con-
tinuous variables were reported in percentages and median
(25th and 75th percentiles) as appropriate. The contemporary
pattern in EMS prenotification over calendar years was ex-
plored, and the trend from years 2003 to 2011 was tested
by using a logistic model including the linear and quadratic
terms of calendar year. As additional hospitals joined GWTG-
Stroke over the course of the study, the temporal trend anal-
yses also were performed among the hospitals participating
in GWTG-Stroke in 2003 and 2004 and continuing participa-
tion during the entire study period (hospital n=137). Potential
variables that might have affected EMS prenotification were
identified in the univariate analyses. Candidate patient vari-
ables included age, sex, race/ethnicity (white, black, Hispanic,
Asian, and other), medical history (including atrial fibrillation or
flutter, coronary artery disease or prior myocardial infarction,
carotid stenosis, diabetes mellitus, hyperlipidemia, heart fail-
ure, hypertension, smoking status, prior stroke or TIA, periph-
eral vascular disease, and prosthetic heart valve), insurance
status (Medicare, Medicaid, no insurance, or other, including
health maintenance organization, Veterans Health Administra-
tion benefits, or private insurance), and arrival during regular
working hours (defined as Monday through Friday between 7
AM and 6 PM). Hospital variables that might have affected EMS
prenotification included number of beds, geographic region
(Midwest, Northeast, West, South), teaching status, average
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number of patients with ischemic stroke/TIA treated annually,
and average number of patients treated with tPA annually. A
multivariable logistic regression analysis, with a generalized
estimating equations approach to adjust for within-hospital
clustering, was performed to determine factors significantly
associated with EMS prenotification. Interactional testing was
performed to examinewhether the relationship of EMS prenoti-
fication and race wasmodified by different geographic regions.
Time trends also were tested in a generalized estimating equa-
tions model that adjusted for patient and hospital characteris-
tics. Because the degree of stroke severity is a potential fac-
tor affecting both EMS prenotification and patient outcomes,
further sensitivity analyses were done on the subset of pa-
tients with complete NIHSS data available. These analyses
also were performed in the subset of patients arriving within
4.5 hours.
All tests were 2 tailed, with P<0.05 considered the level of
statistical significance. All statistical analyses were performed
in SAS version 9.2 software (SAS Institute, Cary, NC). The
authors had full access to the data and take responsibility for
its integrity. All authors have read and agree to the manuscript
as written.
Results
Our analysis included 371 988 patients with acute ischemic
stroke from 1585 participating sites who arrived by EMS be-
tween 2003 and 2011. A median of 131 patients with acute is-
chemic stroke (25th–75th percentiles: 32–339) were enrolled
per hospital. During this 8-year study period, hospitals reported
prenotification for 249 197 patients arriving by EMS (67.0%). If
limited to the 1395 hospitals with≥10 patients entered during
the study, the mean rate of EMS prenotification was 62.1%; if
limited to the 1089 hospitals with ≥50 patients entered dur-
ing the study, the mean rate of EMS prenotification was 64.1%.
When the analysis was confined to EMS-transported patients
who were potential candidates for tPA treatment under current
expanded treatment guidelines (ie, arriving within 4.5 hours
from symptom onset, n=135 308), prenotification occurred
in 97 511 patients (72.1%). If limited to EMS-transported pa-
tients arriving within 2 hours of symptom onset (n=99 145),
prenotification occurred in 73.0%.
Comparisons of patient- and hospital-level characteristics
for patients with EMS prenotification versus patients without
prenotification are provided in Table 1. Among acute ischemic
stroke cases with EMS prenotification, patients were more
likely to be younger, white, and male and to have a history of
atrial fibrillation. EMS prenotification also occurred more fre-
quently for patients with higher NIHSS scores and for those
arriving during facility off-hours. EMS prenotification was less
likely for patients with a history of previous stroke/TIA, dia-
betes mellitus, peripheral vascular disease, hypertension, dys-
Table 1. Baseline Patient and Hospital Characteristics by
EMS Prenotification Status
EMS No EMS
Prenotification Prenotification
(n=249 197) (n=122 791) P
Age, median (25th–75th
percentiles), y
76 (64–84) 76 (64–84) <0.0001
Male, % 46.6 45.7 <0.0001
Race/ethnicity, %
White, non-Hispanic 74.6 70.2 <0.0001
Black 13.8 18.1
Hispanic 5.6 5.4
Asian 2.3 2.2
Other 3.7 4.1
Insurance status, %
Health maintenance
organization/private
26.1 26.7 <0.0001
Medicare 55.2 54.4
Medicaid/military/Veterans
Health Administration
5.7 6.7
Self/none 3.6 3.8
Arrival off-hours, %* 52.5 52.1 0.0077
Time from symptom onset to
arrival, median (25th-75th
percentiles), min
113 (55–340) 150 (60–445) <0.0001
NIHSS, median (25th–75th
percentiles)
7 (3–15) 6 (3–13) <0.0001
NIHSS, %
>25 2.9 2.1 <0.0001
21–25 4.0 2.8
16–20 6.1 4.4
11–15 7.8 5.9
6–10 12.2 10.0
0–5 23.4 22.5
Not documented 43.5 52.4
Medical history, %
Atrial fibrillation/flutter 23.4 22.3 <0.0001
Prosthetic heart valve 1.6 1.6 0.61
Previous stroke/TIA 34.3 35.1 <0.0001
Coronary artery disease / prior
myocardial infarction
30.5 30.0 0.0028
Carotid stenosis 4.3 4.4 0.31
Diabetes mellitus 31.3 33.3 <0.0001
Peripheral vascular disease 5.1 5.7 <0.0001
Hypertension 80.7 81.8 <0.0001
Smoker 18.1 18.0 0.95
Dyslipidemia 39.6 40.4 <0.0001
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Table 1. Continued.
EMS No EMS
Prenotification Prenotification
(n=249 197) (n=122 791) P
Heart failure 6.0 6.6 <0.0001
Medications before admission, %
Antihypertensive 70.5 71.1 <0.0001
Cholesterol reducer 37.9 38.2 0.18
Diabetic medication 23.2 24.6 <0.0001
Hospital size in beds, median
(25th–75th percentiles), n
362 (260–546) 365 (250–524) <0.0001
Hospital type, % academic 53.4 60.9 <0.0001
Annual volume of ischemic stroke/TIA admissions, %
≥301 45.7 42.8 <0.0001
101–300 45.6 46.0
0–100 8.7 11.1
Annual volume of tPA administration, %
≥11 23.2 19.4 <0.0001
7–10 35.2 32.8
0–6 41.6 47.9
Hospital region, %
West 20.9 12.6 <0.0001
South 35.3 34.7
Midwest 19.3 15.3
Northeast 24.5 37.5
A median of 131 patients with acute ischemic stroke (25th–75th percentiles: 32–339)
were enrolled per hospital.
*Arrival at the hospital that did not occur during Monday through Friday, 7:00 AM to
6:00 PM.
NIHSS values were recorded in 199 154 patients. Sex was missing in 0.08%,
race/ethnicity in 0.06%, medical history in 6.5%, teaching status 4.4%, and number of
hospital beds in 6.5%.
lipidemia, or heart failure. Time from symptom onset to hospi-
tal arrival was shorter in patients with prenotification. Patients
with EMS prenotification were more likely to be transported to
hospitals that were nonacademic, had larger annual volumes
of tPA administration, and were located outside the Northeast.
Patient- and hospital-level characteristics that were signif-
icantly associated with EMS prenotification are shown in Ta-
ble 2. Patient characteristics associated with increased odds
of EMS prenotification were younger age; white race; past
medical history of atrial fibrillation; and no medical history of
previous stroke/TIA, diabetes mellitus, or peripheral vascular
disease. In particular, black patients had decreased odds of
EMS prenotification when compared to their white counter-
parts, with an adjusted odds ratio of 0.94 (95% confidence
interval 0.92–0.97, P<0.0001). Hospital characteristics asso-
ciated with decreased odds of EMS prenotification were aca-
Table 2. Patient- and Hospital-Level Characteristics
Associated With EMS Prenotification
Adjusted 95% Confidence
Ratio Interval P
Age (per 10 y) 0.98 0.98–0.99 0.002
Female (vs male) 0.99 0.98–1.00 0.03
Race/ethnicity (reference non-Hispanic white)
Black 0.94 0.92–0.97 <0.0001
Hispanic 1.00 0.98–1.03 0.81
Asian 0.97 0.93–1.01 0.11
Other 0.89 0.83–0.96 0.003
Medical history
Atrial fibrillation/flutter 1.05 1.03–1.06 <0.0001
Previous stroke/TIA 0.98 0.96–0.99 0.0007
Diabetes mellitus 0.96 0.95–0.97 <0.0001
Peripheral vascular disease 0.94 0.92–0.97 <0.0001
Annual tPA volume (reference ≥21 patients/y)
0–10 0.77 0.61–0.96 0.02
11–20 1.12 0.85–1.47 0.43
Academic center 0.65 0.56–0.75 <0.0001
Region (reference Northeast)
West 2.04 1.63–2.55 <0.0001
South 1.29 1.07–1.55 0.007
Midwest 1.70 1.39–2.07 <0.0001
demic affiliation, Northeast location, and smaller annual tPA
volumes. When the analysis was confined to patients arriving
within 4.5 hours and patients with stroke severity documented
with adjustment for NIHSS, the findings were, with few ex-
ceptions, similar (Table 3 and online-only Data Supplement
Table II). Greater stroke severity, as indexed by NIHSS, was
significantly associated with increased odds of EMS prenotifi-
cation.
There was substantial variation by hospital in the use of
EMS prenotification, ranging from 0% to 100%, among hospi-
tals with≥10 patients (prenotification median 70%; 25th–75th
percentiles: 34.0%–92.9%). There was also substantial varia-
tion in use of EMS prenotification by state (Figure 1), ranging
from a low of 19.7% in Washington, DC, to a high of 93.4%
in Montana (hospital-level analyses). The numbers of patients
and hospitals from each state, along with patient-level rates
by state, are shown in online-only Data Supplement Table III.
EMS prenotification rates among patients transported by
EMS showed a modest and statistically significant increase,
from 58.0% in 2003 to 60.7% in 2004, 66.1% in 2005, 67.0%
in 2006, 68.3% in 2007, and 71.1% in 2008, followed by a
decline to 65.4% in 2009, 65.5% in 2010, and 67.3% as of April
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Table 3. Patient- and Hospital-Level Characteristics
Associated With EMS Prenotification for Patients Arriving
Within 4.5 Hours With Complete NIHSS Data (N=90 135)
Adjusted 95% Confidence
Odds Ratio Interval P
Age (per 10 y) 0.99 0.98–0.99 0.005
Female (vs male) 1.00 0.97–1.02 0.67
Race/ethnicity (reference non-Hispanic white)
Black 0.89 0.85–0.93 <0.0001
Hispanic 1.00 0.95–1.05 0.95
Asian 0.90 0.83–0.97 0.008
Other 0.90 0.81–0.99 0.03
Medical history
Atrial fibrillation/flutter 1.00 0.97–1.03 0.88
Previous stroke/TIA 0.98 0.95–1.01 0.12
Diabetes mellitus 0.98 0.96–1.01 0.20
Peripheral vascular disease 0.94 0.89–0.99 0.03
Annual tPA volume (reference ≥21 patients/y)
0–10 0.83 0.65–1.06 0.14
11–20 1.15 0.86–1.55 0.34
NIHSS (per 5 units) 1.05 1.04–1.06 <0.001
Academic center 0.69 0.59–0.82 <0.001
Region (reference Northeast)
West 2.18 1.68–2.84 <0.0001
South 1.31 1.07–1.61 0.01
Midwest 1.52 1.22–1.89 0.0002
2011 (P temporal trend <0.0001) (Figure 2). When the anal-
yses were confined to the 137 hospitals continuously partici-
pating in GWTG-Stroke, similar temporal trends were observed
(online-only Data Supplement Figure I). Generalized estimating
equations models adjusting for patient and hospital character-
istics also showed significant linear and quadratic time trend
overall and for continuously participating hospitals.
Discussion
Our analysis of patients with acute ischemic stroke arriving
to 1585 hospitals participating in GWTG-Stroke demonstrates
that EMS prenotification is generally underutilized in contem-
porary practice. Prenotification rates have shown only modest
improvements from 2003 to 2011. Furthermore, EMS preno-
tification practices show striking variation by hospital, ranging
from 0% to 100%. Variation also occurred by state and ge-
ographic region. Disparities in EMS prenotification use, par-
ticularly in regard to patient age, race/ethnicity, and certain
comorbid conditions, have been identified in this study and
are important to address. Hospital factors, including size, ge-
ographic location, and annual ischemic stroke and annual tPA
volumes, also were associated significantly with EMS preno-
tification. These findings demonstrate gaps in the quality of
stroke care provided and support the need for initiatives
targeted to improve EMS prenotification rates on a national
level.
The challenges in meeting the door-to-needle performance
metric are recognized and well studied.5 In a situation in which
every minute counts, hospitals and policy makers alike are
continuously reevaluating current processes of stroke care in
the hope of uncovering methods to improve the timeliness of
thrombolytic treatment administration. Prior studies and un-
published data from our analysis propose EMS prenotification
as an important strategy for addressing this concern.8–12,15 Re-
sults from these studies suggest that prenotification practices
are associated with more timely evaluation and treatment of
patients with acute ischemic stroke. EMS prenotification has
been found to facilitate faster imaging and imaging interpreta-
tion times, to increase patient eligibility for and administration
of tPA, and to increase rates of tPA administered within 60min-
utes of arrival.
Among GWTG-Stroke hospitals in the United States, one
third of all EMS-transported patients do not receive the benefits
of prenotification. This highlights a specific area for improve-
ment in stroke treatment practices. A previous study of 118
patients arriving by EMS to the emergency department within 6
hours of symptom onset reported an EMS prenotification rate
of 37% and identified EMS prenotification as an underutilized
practice.15 Although our analysis reflects a more encouraging
national EMS prenotification rate, we found widespread varia-
tion in prenotification rates at the hospital, state, and regional
levels. Although this range demonstrates that some institutions
might require more targeted improvement efforts than others
in this regard, it also suggests that very high EMS prenotifi-
cation rates are feasible and are a reasonable goal. Further
investigation into these differential rates could better inform
both hospitals and EMS personnel on practices that allow for
higher prenotification rates.
Our study further evaluated patient- and hospital-level
disparities in EMS prenotification. Age, race/ethnicity, history
of atrial fibrillation, and history of diabetes were identified as
patient determinants, whereas size, geographic location, and
annual volume of patients administered tPA were noted to
be significant hospital factors. Older patients and black pa-
tients were less likely to have EMS prenotification. EMS were
also less likely to prenotify academic hospital facilities and
sites that typically have smaller annual tPA volumes. Region-
ally, the practice of EMS prenotification is least established in
the Northeast. Such patient-level disparities have been docu-
mented previously in other settings, both in regard to stroke
patient management and more broadly in other areas of health
care. Inequalities in the use and timeliness of reperfusion thera-
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Figure 1. Comparison of EMS prenotification rates by state at the hospital level. States with <4 participating hospitals were excluded.
pies for older, minority, female patients with acute ST-elevation
myocardial infarction have been described.16,17 In terms of
stroke care, older age and black ethnicity have been associated
with decreased odds of door-to-needle times ≤60 minutes for
acute ischemic stroke.5 A recent review by Cruz-Flores et al18
highlighted the differential burden of disease and disparities
in quality of care delivered to minority patients with stroke.
They found that in comparison to white counterparts, minor-
ity patients have higher incidence and prevalence of stroke.
Black patients, in particular, have a markedly higher burden of
disease, with higher rates of functional impairment and death
after stroke. Furthermore, minorities tended to have poorer
access to acute stroke care, stroke rehabilitation, and stroke
prevention services. Other studies have shown that even when
minorities have access to medical care, disparities exist in the
quality of stroke care received. Blacks were less likely to un-
dergo comprehensive evaluation of an acute stroke and were
also less likely to receive tPA.18–21 Further research focusing
on these disparities, including potential strategies to counter
them, will be crucial to the advancement of healthcare equality.
These data support the need for targeted initiatives to im-
prove the national rate of EMS prenotification. This begins with
increasing awareness of the benefits of prenotification and dis-
parities in its use among EMS personnel and stroke teams at
receiving hospitals. EMS personnel should receive adequate
training and protocols that help rapidly and accurately identify
potential acute stroke patients and participate in a system of
care that includes prenotifying hospitals.
Previous analyses have emphasized the importance of defin-
ingminimum thresholds for stroke in EMS training, with a focus
on the type of data required for activation of hospital-based
stroke teams.6 Implementation of standardized tools for the
detection of acute stroke in the ambulatory setting can further
streamline the prenotification process.6,15
A stroke system-of-care process measure reporting the use
of EMS prenotification should be considered. Furthermore,
hospital-based stroke teams should be provided information
on improved stroke outcomes associated with prenotification.
Institutions should be encouraged to work with EMS and im-
plement stroke systems of care in response to prenotification.
Protocols should be in place to facilitate earlier activation of
the stroke team and preparation of imaging modalities once
prenotification is received so that tPA can be promptly initiated
when indicated.2,5,6,11
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Figure 2. Temporal trends in EMS prenotification, by calendar years, from 2003 to 2011 among patients with acute ischemic stroke transported
by EMS. Hospitals N=1585; patients N=371 988. P temporal trend <0.0001.
Limitations
The present study has several limitations. First, participation in
GWTG-Stroke is voluntary. Although it includes>1500 US hos-
pitals, the GWTG-Stroke registry could self-select institutions
with greater interest in quality improvement, and thus bet-
ter process performance, than non–GWTG-Stroke centers.5,13
Therefore, our analysis might have overestimated the current
use of EMS prenotification. Second, as with all registries, the
data presented here are dependent on the accuracy and com-
pleteness of abstraction from the medical records. Complete
documentation might not have occurred for all patients preno-
tified by EMS. Conversely, specific stroke patient prenotifi-
cation could have been documented but could have not ac-
tually occurred. The assessment of EMS prenotification was
dichotomized as “present” or “absent,” and additional infor-
mation that might have been communicated to hospitals, such
as prehospital stroke screening results and type of symptoms,
was not captured. We do not have data on how prenotification
varied by each EMS agency. We also do not have any data on
the type of first responder, the level of training of the rendering
prehospital providers, EMS protocols in use, or characteristics
of the EMS agencies. Although our analysis identified several
patient and hospital characteristics that affect EMS prenoti-
fication, there are likely other important influencing factors
not captured here, including EMS agency characteristics and
the existence of regional stroke systems of care with routing
of patients with stroke directly to designated stroke centers.
These are important factors to consider, and further research
is warranted. Residual measured and unmeasured confound-
ing variables might have influenced some or all of the findings.
With our large study population, small differences in the data
in absolute terms were still highly statistically significant.
Conclusions
Despite guideline recommendations and potential benefits,
EMS prenotification occurred in only two thirds of patients with
acute ischemic stroke transported by EMS to GWTG-Stroke–
participating hospitals, with only a modest improvement over
the past 8 years. Use of EMS prenotification also varies widely
by hospital, state, and geographic region among patients trans-
ported to GWTG-Stroke hospitals. Disparities in use of EMS
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prenotification, particularly in regard to age, race/ethnicity,
and certain comorbid conditions, have been identified in this
study and will be important to address. Hospital factors, in-
cluding size, geographic location, and annual ischemic stroke
and tPA volumes, also were associated significantly with EMS
prenotification. These findings demonstrate gaps in the qual-
ity of stroke care provided and support the need for targeted
initiatives to improve EMS prenotification rates on a national
level.
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